The nature of the merger with Ireland-based Allergan has renewed debate over corporate tax avoidance. Here’s why such deals often meet political opposition
US drugs giant Pfizer is merging with Irish-headquartered Allergan in a record-breaking $155bn (£100bn) deal. It is the largest so-called tax inversion move to date, and will bring huge tax savings to Pfizer as it shifts its headquarters from the US to tax-light Ireland.
Related: Pfizer's $155bn takeover of Allergan set to prompt tax row
Related: Corporate inversion - moving the head office for tax purposes
Continue reading...from Mergers and acquisitions | The Guardian http://ift.tt/1P3uPzE
No comments:
Post a Comment